tiprankstipranks
Trending News
More News >
Inovio Pharmaceuticals (INO)
NASDAQ:INO
US Market

Inovio Pharmaceuticals (INO) Income Statement

Compare
5,831 Followers

Inovio Pharmaceuticals Income Statement

Last quarter (Q1 2025), Inovio Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Inovio Pharmaceuticals's net income was $-19.69B. See Inovio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 217.76K$ 832.01K$ 10.26M$ 1.77M$ 7.41M
Gross Profit
$ -2.91M$ -2.67M$ 4.77M$ -2.96M$ -86.83M
Operating Expenses
$ 111.09M$ 144.77M$ 277.84M$ 302.99M$ 131.49M
Depreciation and Amortization
$ 3.13M$ 3.50M$ 5.50M$ 4.73M$ 4.63M
EBITDA
$ -103.95M$ -130.39M$ -270.90M$ -296.56M$ -149.56M
Operating Income
$ -112.40M$ -143.94M$ -267.57M$ -301.22M$ -124.08M
Other Income/Expenses
$ -107.14B$ 8.82M$ -10.08M$ -2.01M$ -38.81M
Pretax Income
$ -107.25B$ -135.12M$ -277.65M$ -303.22M$ -162.89M
Net Income
$ -107.25M$ -135.12M$ -287.66M$ -305.38M$ -215.09M
Per Share Metrics
Basic EPS
$ -3.95$ -6.09$ -14.47$ -17.55$ -16.64
Diluted EPS
$ -3.95$ -6.09$ -14.47$ -17.55$ -16.64
Weighted Average Shares Outstanding
27.16M 22.17M 19.89M 17.40M 12.93M
Weighted Average Shares Outstanding (Diluted)
27.16M 22.17M 19.89M 17.40M 12.93M
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis